Rebirthel Co., Ltd.
PrivateLast Round
Series B
Dec 1, 2022
Total Funding Raised
$1.7M
Momentum
Top 25%
of companies Caplight tracks
Company Overview
Rebirthel Co., Ltd. operates in Healthcare & Life Sciences and is based in Kyoto. Its latest recorded funding round was a Series B round in December 2022.
Rebirthel Co., Ltd. is a biotechnology company that develops allogeneic T-cell immunotherapies using iPS cells to treat cancer and other immune-related diseases.
Sector
Healthcare & Life Sciences
Verticals
Biotechnology, Drug Discovery, Clinical Trials
Business Model
B2B
Customer Profile
Revenue Share, Services & Consulting
AI Layer
Non-AI
Historical Pricing
Historical view of private secondary pricing and transaction trends.
Rebirthel Co., Ltd. Comparables
Compare Rebirthel Co., Ltd. with similar companies based on industry and business-model similarity.
| Company | Similarity | Market Cap |
|---|---|---|
| Shoreline Biosciences | 83% | |
| Cartherics | 83% | |
| Neukio Biotherapeutics | 83% |
For institutional investors. Book with your work email.
Rebirthel Co., Ltd. Funding Rounds
Historical fundraising activity
| Round | Date | Amount Raised | Valuation | Investors | Sources |
|---|---|---|---|---|---|
| Series B | Dec 1, 2022 | ||||
| Seed | Mar 30, 2020 |
For institutional investors. Book with your work email.
Key People
Founding team and executive leadership
For institutional investors. Book with your work email.
Rebirthel Co., Ltd. Investors
Notable investors and investment history
| Investor | Rounds |
|---|---|
| Chushin Venture Capital | Series B |
| 株式会社ヘルスケア・イノベーション | Series B |
| Kagawa Securities Co., Ltd. | Series B |
| Nissei Capital | Series B |
| Japan Science and Technology Agency | Seed, Series B |
| Fujifilm Corporation | Series B |
Market signals
Structured signals derived from secondary market and firmographic data.
- Sep 13, 2026
Monthly visitors grew 52% MoM.
- Sep 10, 2025
Partnering with Eutilex to develop next-generation CAR-T therapies.
For institutional investors. Book with your work email.
Rebirthel Co., Ltd. Filings
Explore SEC and related filing metadata, where available.
| Type | Date | Amount Offered | Amount Sold | Filing | Pages | Download |
|---|
Filing documents are not displayed on this public page. Request access to learn about available coverage.
Book a demoFor institutional investors. Book with your work email.
Frequently Asked Questions
Common questions about Rebirthel Co., Ltd.'s valuation, stock price, and market status.
Is Rebirthel Co., Ltd. a public or private company?
Rebirthel Co., Ltd. is a private company.
What is the current stock price of Rebirthel Co., Ltd.?
Rebirthel Co., Ltd. is a private company, so its shares have no public market price. Caplight tracks Rebirthel Co., Ltd.'s secondary market activity and provides MarketPrice™ estimates of its share price to Caplight users.
How much is Rebirthel Co., Ltd. worth (valuation)?
Valuation information for Rebirthel Co., Ltd. is not publicly available.
Can I buy Rebirthel Co., Ltd. stock?
Rebirthel Co., Ltd. shares may be available on secondary markets subject to transfer restrictions. Caplight facilitates secondary market transactions for accredited investors.
When was Rebirthel Co., Ltd.'s last funding round?
Rebirthel Co., Ltd.'s most recent funding round was Series B on December 1, 2022.
Who are the main investors in Rebirthel Co., Ltd.?
Key investors in Rebirthel Co., Ltd. include Chushin Venture Capital, 株式会社ヘルスケア・イノベーション, Kagawa Securities Co., Ltd., Nissei Capital, Japan Science and Technology Agency.
Will Rebirthel Co., Ltd. IPO soon?
No public IPO plans have been announced for Rebirthel Co., Ltd..
How can I track Rebirthel Co., Ltd. secondary market activity?
Caplight tracks bids, offers, and trades in Rebirthel Co., Ltd.'s shares on secondary markets.